Currently out of the existing stock ratings of Joseph France, 45 are a BUY (70.31%), 19 are a HOLD (29.69%).

Joseph France

Work Performance Price Targets & Ratings Chart

Analyst Joseph France, currently employed at SIDOTI, carries an average stock price target met ratio of 67.05% that have a potential upside of 19.55% achieved within 262 days.

Joseph France’s has documented 125 price targets and ratings displayed on 23 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ACHC, Acadia Healthcare Company at 14-Sep-2023.

Wall Street Analyst Joseph France

Analyst best performing recommendations are on MOH (MOLINA HEALTHCARE).
The best stock recommendation documented was for HCA (HCA HOLDINGS) at 7/9/2021. The price target of $235 was fulfilled within 11 days with a profit of $24.15 (11.45%) receiving and performance score of 10.41.

Average potential price target upside

CI Cigna Corp CNC Centene Corp HCA HCA Holdings MOH Molina Healthcare THC Tenet Healthcare UHS Universal Health Services UNH UnitedHealth Group ACHC Acadia Healthcare Company ANTM Anthem CVS CVS Health Corp CYH Community Health Systems ENSG The Ensign Group HUM Humana CCRN Cross Country Healthcare ELV Elevance Health AMED Amedisys HR Healthcare Realty Trust USPH US Physicalrapy WBA Walgreens Boots Alliance EVHC Envision Healthcare Holdings LTC LTC Properties OHI Omega Healthcare Investors SBRA Sabra Healthcare REIT

Analyst name

Rating

Rating initiation date

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

Since 02-Aug-2024

$305

$26.05 (9.34%)

$300

7 days ago
(05-Jan-2026)

0/9 (0%)

$21.03 (7.41%)

Buy

Since 10-Oct-2019

$320

$41.05 (14.72%)

$405

7 days ago
(05-Jan-2026)

11/18 (61.11%)

$36.03 (12.69%)

493

Hold

Since 12-Nov-2025

$294

$15.05 (5.40%)

$372

2 months ago
(12-Nov-2025)

6/8 (75%)

$22.52 (8.30%)

304

Buy

Since 09-May-2022

$333

$54.05 (19.38%)

$380

2 months 8 days ago
(04-Nov-2025)

8/10 (80%)

$76.55 (29.85%)

880

Buy

Since 16-May-2022

$375

$96.05 (34.43%)

$438

2 months 8 days ago
(04-Nov-2025)

3/8 (37.5%)

$118.55 (46.23%)

179

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Joseph France?

On 2012

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?